Atlas Trials

Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5

Clinical trial NCT00722384 · COMPLETED

Trial details

NCT number
NCT00722384
Sponsor
OPKO Health, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2004-08-01
Primary completion
2007-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.